Chemical Compound Review:
Clinoril 2-[(3E)-6-fluoro-2-methyl-3- [(4...
Synonyms:
Klinoril, Sulindal, sulindac, Arthrobid, Chibret, ...
- Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R., Offerhaus, G.J. N. Engl. J. Med. (1993)
- Nephrotic syndrome associated with sulindac. Lomvardias, S., Pinn, V.W., Wadhwa, M.L., Koshy, K.M., Heller, M. N. Engl. J. Med. (1981)
- Sulindac. A potentially renal-sparing nonsteroidal anti-inflammatory drug. Bunning, R.D., Barth, W.F. JAMA (1982)
- Pancreatitis after administration of sulindac. Lilly, E.L. JAMA (1981)
- Auditory and visual hallucinations associated with sulindac: focus on prostaglandin synthesis and psychotic symptoms. Sabet-Sharghi, F., Camara, E.G., Stagno, S. Psychosomatics. (1990)
- Aberrant crypt foci of the colon as precursors of adenoma and cancer. Takayama, T., Katsuki, S., Takahashi, Y., Ohi, M., Nojiri, S., Sakamaki, S., Kato, J., Kogawa, K., Miyake, H., Niitsu, Y. N. Engl. J. Med. (1998)
- Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F., Taketo, M.M. Cell (1996)
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Tsujii, M., DuBois, R.N. Cell (1995)
- Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. Ciabattoni, G., Cinotti, G.A., Pierucci, A., Simonetti, B.M., Manzi, M., Pugliese, F., Barsotti, P., Pecci, G., Taggi, F., Patrono, C. N. Engl. J. Med. (1984)
- Role of BAX in the apoptotic response to anticancer agents. Zhang, L., Yu, J., Park, B.H., Kinzler, K.W., Vogelstein, B. Science (2000)
- An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs. Stern, R.S., Bigby, M. JAMA (1984)
- 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. Shureiqi, I., Chen, D., Lee, J.J., Yang, P., Newman, R.A., Brenner, D.E., Lotan, R., Fischer, S.M., Lippman, S.M. J. Natl. Cancer Inst. (2000)
- Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac. Laffi, G., Daskalopoulos, G., Kronborg, I., Hsueh, W., Gentilini, P., Zipser, R.D. Gastroenterology (1986)
- Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Giardiello, F.M., Casero, R.A., Hamilton, S.R., Hylind, L.M., Trimbath, J.D., Geiman, D.E., Judge, K.R., Hubbard, W., Offerhaus, G.J., Yang, V.W. Gastroenterology (2004)
- Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Agarwal, B., Rao, C.V., Bhendwal, S., Ramey, W.R., Shirin, H., Reddy, B.S., Holt, P.R. Gastroenterology (1999)
- Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. Shiff, S.J., Qiao, L., Tsai, L.L., Rigas, B. J. Clin. Invest. (1995)
- The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Pasricha, P.J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A.J., Zahurak, M.L., Piantadosi, S., Hamilton, S.R., Giardiello, F.M. Gastroenterology (1995)
- A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Arber, N., Han, E.K., Sgambato, A., Piazza, G.A., Delohery, T.M., Begemann, M., Weghorst, C.M., Kim, N.H., Pamukcu, R., Ahnen, D.J., Reed, J.C., Weinstein, I.B., Holt, P.R. Gastroenterology (1997)
- Potential effect of sulindac on response of prothrombin-time to oral anticoagulants. Carter, S.A. Lancet (1979)
- Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Spagnesi, M.T., Tonelli, F., Dolara, P., Caderni, G., Valanzano, R., Anastasi, A., Bianchini, F. Gastroenterology (1994)
- Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. Jacoby, R.F., Cole, C.E., Hawk, E.T., Lubet, R.A. Gastroenterology (2004)
- Sulindac and gastric mucosa. Porro, G.B., Petrillo, M., Caruso, E., Fumagalli, M. Lancet (1977)
- Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin. Calin, A., Britton, M. JAMA (1979)
- Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Buttar, N.S., Wang, K.K., Leontovich, O., Westcott, J.Y., Pacifico, R.J., Anderson, M.A., Krishnadath, K.K., Lutzke, L.S., Burgart, L.J. Gastroenterology (2002)
- Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Wong, D.G., Spence, J.D., Lamki, L., Freeman, D., McDonald, J.W. Lancet (1986)
- Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Tsujii, M., Kawano, S., DuBois, R.N. Proc. Natl. Acad. Sci. U.S.A. (1997)
- Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Rüschoff, J., Wallinger, S., Dietmaier, W., Bocker, T., Brockhoff, G., Hofstädter, F., Fishel, R. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. Mahmoud, N.N., Bilinski, R.T., Churchill, M.R., Edelmann, W., Kucherlapati, R., Bertagnolli, M.M. Cancer Res. (1999)
- Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Boolbol, S.K., Dannenberg, A.J., Chadburn, A., Martucci, C., Guo, X.J., Ramonetti, J.T., Abreu-Goris, M., Newmark, H.L., Lipkin, M.L., DeCosse, J.J., Bertagnolli, M.M. Cancer Res. (1996)
- Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites. Rice, P.L., Beard, K.S., Driggers, L.J., Ahnen, D.J. Cancer Res. (2004)
- Primary chemoprevention of familial adenomatous polyposis with sulindac: more questions than answers. Bresalier, R.S. Gastroenterology (2002)
- Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Cruz-Correa, M., Hylind, L.M., Romans, K.E., Booker, S.V., Giardiello, F.M. Gastroenterology (2002)